Roszak Andrzej, Wareńczak-Florczak Zaneta, Bratos Krystyna, Milecki Piotr
Greater Poland Cancer Centre, Department of Gynaecological Radiotherapy and Oncology, Garbary Street 15, 61-866 Poznan, Poland ; Karol Marcinkowski University of Medical Sciences, Department of Electroradiology, Garbary Street 15, 61-866 Poznan, Poland.
Greater Poland Cancer Centre, Department of Gynaecological Radiotherapy and Oncology, Garbary Street 15, 61-866 Poznan, Poland.
Rep Pract Oncol Radiother. 2012 Sep 5;17(6):332-8. doi: 10.1016/j.rpor.2012.07.005. eCollection 2012.
The study was made to evaluate early and late toxicity in a diversified group of patients receiving definitive or adjuvant radiotherapy in terms of clinical diagnosis and treatment methods.
Radiotherapy is a standard way of treatment in cervical and endometrial cancer patients, both as definitive and adjuvant therapy. But every radiation treatment may be involved with toxicity.
A detailed analysis was performed of 263 patients with gynaecological cancer treated with definitive (90 patients with cervical cancer received radiochemotherapy or radiotherapy exclusively) and adjuvant radiotherapy (38 with cervical and 135 with endometrial cancer).
Acute reactions were found in 51.3% and late reactions were found in 14.8% of patients. It was stated that early (p < 0.007) and late (p < 0.003) post radiation reaction appear more frequently in women treated with definitive than adjuvant radiotherapy. The analysis of the whole group revealed higher rate of toxicity, both early and late, in the gastrointestinal tract than in the urinary system (p < 0.004). Comparing the subgroups, it was found that intestinal reactions occurred more frequently in the definitive radiotherapy group than in the adjuvant one. The occurrence of side effects was associated with the prolongation of total irradiation time due to necessary interruptions of radiotherapy. The comparison of the subgroups showed that interruptions occurred more frequently in patients receiving definitive rather than adjuvant radiotherapy (17.7-2.9%).
Definitive radiotherapy compared with adjuvant treatment may by associated with higher percentage of side effects caused by dose of therapy and correlation with chemotherapy.
本研究旨在根据临床诊断和治疗方法,评估接受根治性或辅助性放疗的不同患者群体的早期和晚期毒性。
放疗是宫颈癌和子宫内膜癌患者的标准治疗方式,可作为根治性治疗和辅助性治疗。但每次放疗都可能伴有毒性。
对263例接受根治性放疗(90例宫颈癌患者仅接受放化疗或放疗)和辅助性放疗(38例宫颈癌患者和135例子宫内膜癌患者)的妇科癌症患者进行了详细分析。
51.3%的患者出现急性反应,14.8%的患者出现晚期反应。据指出,接受根治性放疗的女性患者早期(p < 0.007)和晚期(p < 0.003)放疗后反应比接受辅助性放疗的患者更频繁出现。对整个组的分析显示,胃肠道早期和晚期毒性发生率均高于泌尿系统(p < 0.004)。比较亚组发现,根治性放疗组肠道反应比辅助性放疗组更频繁发生。副作用的发生与放疗必要中断导致的总照射时间延长有关。亚组比较显示,接受根治性放疗的患者中断放疗的频率高于接受辅助性放疗的患者(17.7 - 2.9%)。
与辅助性治疗相比,根治性放疗可能因治疗剂量和与化疗的相关性而导致更高比例的副作用。